发明名称 |
DOSING REGIMEN FOR A SELECTIVE S1P1 RECEPTOR AGONIST |
摘要 |
The present invention relates to a dosing regimen for a selective S1P1 receptor agonist, whereby the selective S1P1 receptor agonist is administered to a subject in such a way that during the initial treatment phase the selective S1P1 receptor agonist is administered at a dose which induces desensitization of the heart wherein said dose is below the target dose, and at a dosing frequency that sustains desensitization of the heart, until no further acute heart rate reduction occurs, followed by dose up-titration to the target dose of the selective S1P1 receptor agonist. |
申请公布号 |
US2014303217(A1) |
申请公布日期 |
2014.10.09 |
申请号 |
US201414308598 |
申请日期 |
2014.06.18 |
申请人 |
ACTELION PHARMACEUTICALS LTD |
发明人 |
BROSSARD Patrick;DINGEMANSE Jasper;NAYLER Oliver;SCHERZ Michael;STEINER Beat |
分类号 |
A61K31/426 |
主分类号 |
A61K31/426 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for administering a selective S1P1 receptor agonist or a pharmaceutically acceptable salt thereof to a subject in need thereof wherein during an initial treatment phase the selective S1P1 receptor agonist or pharmaceutically acceptable salt thereof is administered at a dose which induces desensitization of the heart to acute heart rate reduction said dose being below the target dose, and at a dosing frequency that sustains desensitization of the heart, until no further acute heart rate reduction occurs, followed by dose up-titration to the target dose of the selective S1P1 receptor agonist or pharmaceutically acceptable salt thereof. |
地址 |
Allschwil CH |